Alvarsson, M <br/><br/>
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up.  [electronic resource] 

 -  Diabetes, obesity & metabolism  May 2008 
 - 421-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2007.00719.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>Body Weight--drug effects<br/>C-Peptide--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Fasting--blood<br/>Female<br/>Follow-Up Studies<br/>Glucagon<br/>Glyburide--administration & dosage<br/>Glycated Hemoglobin--metabolism<br/>Health Status Indicators<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--blood<br/>Insulin, Long-Acting--administration & dosage<br/>Insulin-Secreting Cells<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Proinsulin--blood<br/>Quality of Life